CIPLA files for a compulsory license against Merck’s Isentress
SpicyIP brings to its readers another spicy post from Suchita Saigal, this time on Complusory Licensing. Suchita provides a possible solution to one of the compulsory licensing issues arising from a recent case involving Merck and Cipla. A recent article published by Moneycontrol states that Mumbai based pharma giant Cipla has applied for a compulsory licence to manufacture Merck’s anti-HIV drug Isentress on the basis that the drug is exorbitantly priced and is inaccessible to needy patients in India. Legislative background Section […]
CIPLA files for a compulsory license against Merck’s Isentress Read More »




